TY - JOUR
T1 - Mechanism of salutary effects of finasteride on post-traumatic immune/inflammatory response
T2 - Upregulation of estradiol synthesis
AU - Frink, Michael
AU - Hsieh, Ya Ching
AU - Hu, Shunhua
AU - Hsieh, Chi Hsun
AU - Pape, Hans Christoph
AU - Choudhry, Mashkoor A.
AU - Schwacha, Martin G.
AU - Bland, Kirby I.
AU - Chaudry, Irshad H.
PY - 2007/11
Y1 - 2007/11
N2 - OBJECTIVE: The aim of this study was to evaluate whether pretreatment with finasteride, a 5α-reductase inhibitor, improves immune functions after trauma-hemorrhage. SUMMARY BACKGROUND DATA: A number of studies have provided evidence for a gender dimorphism in host defense after trauma. Under stress conditions, such as trauma-hemorrhage, androgenic hormones have immunosuppressive effects, leading to increased susceptibility to sepsis, morbidity, and mortality. Testosterone is converted by 5α-reductase to 5α-dihydrotestosterone (DHT), a more potent androgen. METHODS: Male C3H/HeN mice (8-10 weeks) were randomly assigned to receive finasteride or vehicle for 2 days and were then subjected to trauma-hemorrhage or sham operation. Trauma-hemorrhage was induced by a midline laparotomy and approximately 90 minutes of hemorrhagic shock (blood pressure, 35 mm Hg), followed by fluid resuscitation. Animals were killed 2 hours after resuscitation or sham procedure. Plasma levels and Kupffer cell production of cytokines (TNF-α, IL-6, IL-10, MCP-1, KC, and MIP-1α), lung neutrophil infiltration, and edema were evaluated. RESULTS: Finasteride administration prevented the increase in cytokine plasma levels, decreased DHT, and increased 17β-estradiol plasma concentrations. In addition, neutrophil infiltration and edema formation in the lung were reduced by finasteride. The salutary effects of finasteride were abrogated after coadministration with an estrogen receptor inhibitor (ICI 182,780). Increased Kupffer cell cytokine production normally observed after trauma-hemorrhage was prevented by treatment with finasteride. CONCLUSION: These results suggest that inhibition of 5α-reductase leads to the conversion of testosterone to 17β-estradiol, which produces salutary effects on the post-traumatic immune response.
AB - OBJECTIVE: The aim of this study was to evaluate whether pretreatment with finasteride, a 5α-reductase inhibitor, improves immune functions after trauma-hemorrhage. SUMMARY BACKGROUND DATA: A number of studies have provided evidence for a gender dimorphism in host defense after trauma. Under stress conditions, such as trauma-hemorrhage, androgenic hormones have immunosuppressive effects, leading to increased susceptibility to sepsis, morbidity, and mortality. Testosterone is converted by 5α-reductase to 5α-dihydrotestosterone (DHT), a more potent androgen. METHODS: Male C3H/HeN mice (8-10 weeks) were randomly assigned to receive finasteride or vehicle for 2 days and were then subjected to trauma-hemorrhage or sham operation. Trauma-hemorrhage was induced by a midline laparotomy and approximately 90 minutes of hemorrhagic shock (blood pressure, 35 mm Hg), followed by fluid resuscitation. Animals were killed 2 hours after resuscitation or sham procedure. Plasma levels and Kupffer cell production of cytokines (TNF-α, IL-6, IL-10, MCP-1, KC, and MIP-1α), lung neutrophil infiltration, and edema were evaluated. RESULTS: Finasteride administration prevented the increase in cytokine plasma levels, decreased DHT, and increased 17β-estradiol plasma concentrations. In addition, neutrophil infiltration and edema formation in the lung were reduced by finasteride. The salutary effects of finasteride were abrogated after coadministration with an estrogen receptor inhibitor (ICI 182,780). Increased Kupffer cell cytokine production normally observed after trauma-hemorrhage was prevented by treatment with finasteride. CONCLUSION: These results suggest that inhibition of 5α-reductase leads to the conversion of testosterone to 17β-estradiol, which produces salutary effects on the post-traumatic immune response.
UR - http://www.scopus.com/inward/record.url?scp=35648943685&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=35648943685&partnerID=8YFLogxK
U2 - 10.1097/SLA.0b013e318158fca0
DO - 10.1097/SLA.0b013e318158fca0
M3 - Article
C2 - 17968177
AN - SCOPUS:35648943685
VL - 246
SP - 836
EP - 843
JO - Annals of Surgery
JF - Annals of Surgery
SN - 0003-4932
IS - 5
ER -